newsare.net
Global pharmaceutical majors and generic drugmakers chopped by 53per cent on average prices of some of their off-patent products in the latest bidding round under China's national bulk-buy program, government officials said late on Friday.Drugmakers slash prices to be eligible for China's bulk-buy program
Global pharmaceutical majors and generic drugmakers chopped by 53per cent on average prices of some of their off-patent products in the latest bidding round under China's national bulk-buy program, government officials said late on Friday. Read more